An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections (vol 8, pg 1145, 2022)ACS CENTRAL SCIENCEIF10.42022-09-060OAAI
Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trialJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22021-09-0131OAAI
Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthmaSCIENCE TRANSLATIONAL MEDICINEIF14.62018-11-2132PREAI
Impact of antiviral therapy for acute obstructive bronchitis in preschool childrenEUROPEAN RESPIRATORY JOURNALIF212017-12-060PRE
The efficacy of antiviral therapy of acute respiratory infections in paediatric practiceEUROPEAN RESPIRATORY JOURNALIF212017-12-060PRE
Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82016-08-3036PREAI
A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discoveryJOURNAL OF COMPUTER-AIDED MOLECULAR DESIGNIF3.12015-02-2423PREAI
Retinal Toxicity, in vivo and in vitro, Associated with Inhibition of Nicotinamide PhosphoribosyltransferaseTOXICOLOGICAL SCIENCESIF4.12014-12-1176OAAI
Fragment-Based Identification of Amides Derived from trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)JOURNAL OF MEDICINAL CHEMISTRYIF6.82014-01-2245PREAI
A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective InhibitorsJOURNAL OF IMMUNOLOGYIF3.42013-09-01116OAAI
Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-07-3184PREAI
Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-06-1369PREAI
Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2JOURNAL OF MEDICINAL CHEMISTRYIF6.82013-05-3169PREAI
Preclinical Pharmacokinetics and Efficacy Assessment of a Potent and Selective MEK Inhibitor, GDC-0623EUROPEAN JOURNAL OF CANCERIF7.12012-11-011PREAI
Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2JOURNAL OF MEDICINAL CHEMISTRYIF6.82012-06-2875PREAI
Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-06-1196PREAI
Discovery of a biologically active thiostrepton fragmentJOURNAL OF THE AMERICAN CHEMICAL SOCIETYIF15.62005-10-0670PREAI
Total synthesis of thiostrepton. Assembly of key building blocks and completion of the synthesisJOURNAL OF THE AMERICAN CHEMICAL SOCIETYIF15.62005-07-1994PREAI
Total synthesis of thiostrepton.: Retrosynthetic analysis and construction of key building blocksJOURNAL OF THE AMERICAN CHEMICAL SOCIETYIF15.62005-07-19127PREAI
Construction of substituted N-hydroxyindoles:: Synthesis of a nocathiacin I model systemANGEWANDTE CHEMIE-INTERNATIONAL EDITIONIF16.92005-06-0656PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向